Sort
15,842 grants matching “pancreatic cancer”
Modeling response to MAPK Inhibitors
$572,859Wolfgang Michael Korn · Oregon Health & Science University · U54 · FY2014 · CA
Synthetic circuits that drive infiltration of therapeutic T cells into immunologically cold tumors
$572,845Wendell A Lim · University Of California, San Francisco · U01 · FY2023 · CA
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
$572,715Debabrata Mukhopadhyay · Mayo Clinic Rochester · R01 · FY2012 · CA
Develop Conditionally Armored CAR Macrophage Therapy for Pancreatic Cancer
$572,707Pingping Hou · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$572,667Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$572,667Cullen Mitsuo Taniguchi · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer
$572,502Gerardo Guillermo Mackenzie · University Of California At Davis · R01 · FY2025 · CA
Harnessing TNFa Signaling To Improve Therapeutic Response In Pancreatic Cancer
$572,447Kian H Lim · Washington University · R01 · FY2024 · CA
Proteomics Biomarkers Development Laboratory
$572,408Samir M Hanash · Fred Hutchinson Cancer Research Center · U01 · FY2007 · CA
The connection of innate and adaptive anti-cancer immunity
$572,121John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease
$571,606Adam O Goldstein · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Physical Activity, Energy Balance, and Cancer
$571,550Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma
$571,498Christopher A Klug · University Of Alabama At Birmingham · P50 · FY2013 · CA
A Dual Molecular/Tumor Targeting Therapy for PanCa
$571,402Synergene Therapeutics, Inc. · R42 · FY2004 · CA
METABOLIC INTERVENTIONS TO HALT PANCREATIC CANCER
$571,350Sanford Burnham Prebys Medical Discovery Institute · · FY2024 · Defense Health Agency
IMMUNOLOGIC REJECTION OF PANCREATIC CANCER WITHOUT AUTOIMMUNE SIDE EFFECTS
$571,075The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2015 · Department of the Army
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
$570,850Debabrata Mukhopadhyay · Mayo Clinic Jacksonville · R01 · FY2020 · CA
The adaptive kinome in pancreatic cancer
$570,696Jen Jen Yeh · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease
$570,092Adam O Goldstein · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
$570,035Kristy Perez · Civatech Oncology, Inc. · R44 · FY2018 · CA
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
$569,944Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
Multiplexed Serum Biomarkers for Pancreatic Cancer
$569,921Anna E Lokshin · University Of Pittsburgh At Pittsburgh · U01 · FY2006 · CA
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
$569,902Adam I Marcus · Emory University · P01 · FY2023 · CA
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
$569,704Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Multiplexed imaging of biliary intra-epithelial neoplasia
$569,599Eric J Seibel · University Of Washington · R01 · FY2017 · CA